Insider · CIK 0001738885
Mark Bodmer
Files at EVLO (Evelo Biosciences, Inc.). First filing Nov 3, 2023, latest Nov 8, 2023.
In brief
Mark Bodmer files SEC Form 4 as president at EVLO (Evelo Biosciences, Inc.). Since Nov 3, 2023, Mark Bodmer has reported 0 open-market buys worth $0 and 2 open-market sells worth $3,306, the latest filed on Nov 8, 2023.
A track record needs three past buys with six months of prices behind them; Mark Bodmer has 0, so none is measured yet.
The newest scored trade: sold $1,044 of EVLO on Nov 8, 2023, filed Nov 8, 2023, scored 5 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EVLO: Evelo Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 5Weak | Evelo Biosciences, Inc. | $1,044 3,163 shares | -11% | - | |
| 5Weak | Evelo Biosciences, Inc. | $2,262 6,854 shares | -24% | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | EVLO Evelo Biosciences, Inc. | MOption exercise Common Stock10b5-1 | +6,625 | - | - | 28,895 | Nov 8, 2023 |
| Nov 8, 2023 | EVLO Evelo Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -3,163 | $0.33 | $1,044 | 25,732 | Nov 8, 2023 |
| Nov 7, 2023 | EVLO Evelo Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -6,625 | $0.00 | $0 | 6,625 | Nov 8, 2023 |
| Nov 1, 2023 | EVLO Evelo Biosciences, Inc. | MOption exercise Common Stock10b5-1 | +12,500 | - | - | 29,124 | Nov 3, 2023 |
| Nov 2, 2023 | EVLO Evelo Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -6,854 | $0.33 | $2,262 | 22,270 | Nov 3, 2023 |
| Nov 1, 2023 | EVLO Evelo Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -12,500 | $0.00 | $0 | 25,000 | Nov 3, 2023 |
Questions about Mark Bodmer
Answered from the filings on this page, as of the latest one.
Is Mark Bodmer buying or selling?
Not in the last 12 months. Mark Bodmer's latest open-market trade on SEC Form 4 was sold $1,044 of EVLO on Nov 8, 2023.
How did Mark Bodmer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark Bodmer has 0.
Where does Mark Bodmer file Form 4?
Mark Bodmer has filed Form 4 at EVLO (Evelo Biosciences, Inc.) as CSO, President of R&D. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.